Chapter 4 - The Boardroom Door Opened
Daniel walked into Brightwell’s emergency review meeting at 8:03 the next morning.
He stopped at 8:04.
Because I was sitting at the head of the table.
For several seconds, he simply stared at me.
Around us sat Sarah, Jonathan, two outside compliance attorneys, Brightwell’s chief scientific officer, and an independent forensic accountant.
Daniel looked at the company logo behind my chair.
Then at me.
“No.”
I almost smiled.
“Good morning.”
“What are you doing here?”
Sarah answered.
“Mrs. Hayes is Brightwell’s founder and majority shareholder.”
Daniel looked as if someone had removed the floor beneath him.
“You said you were consulting.”
“You never asked.”
“You own Brightwell?”
“Enough of it.”
His face turned pale.
Brightwell’s name had been deliberately kept off many early project documents because our investment operated through a research fund.
Daniel had spent eighteen months presenting reports to intermediaries.
He never knew whose money funded him.
Until now.
“You invested in my project?”
“Yes.”
He looked around the room.
Then something changed.
Not humiliation.
Fear.
“Emily, shut this meeting down.”
“No.”
“You don't know what Keller will do.”
Jonathan leaned forward.
“We’re not here to discuss Keller’s feelings.”
Daniel stared at him.
“You.”
Jonathan slid Vanessa’s forged ethics report across the table.
“Someone used my signature.”
Daniel refused to touch it.
I spoke.
“Did Noah and Lucas receive your experimental vector?”
Silence.
“Daniel.”
“Yes.”
Sarah inhaled sharply.
“Were they enrolled in an authorized trial?”
“No.”
“Was there emergency approval?”
Daniel said nothing.
Jonathan answered for him.
“No.”
“Did Brightwell money pay for their treatment?”
Daniel looked at me.
“Partly.”
“How much?”
“I don't know.”
“Try again.”
“Emily—”
“How much?”
“Maybe nine hundred thousand.”
Sarah spoke calmly.
“$1.84 million.”
Daniel closed his eyes.
I thought of every mortgage payment I had stretched.
Every dinner I skipped with friends because I thought Daniel needed money.
Every Sunday phone call.
“Why?”
He leaned forward.
“Because they were dying.”
The room changed.
For the first time, Daniel sounded like a doctor instead of a liar.
“Michael died from the same mutation. Noah and Lucas had it. Their cardiac function was deteriorating.”
“So you experimented on them?”
“We had animal data.”
“You had no pediatric approval.”
“We didn't have time.”
Jonathan's voice hardened.
“Then you request emergency authorization.”
“Keller said it would take months.”
“Keller lied.”
“I know that now.”
Something in Daniel's answer bothered me.
“When did you realize?”
He looked at the table.
“After Lucas crashed.”
I leaned back.
“And you kept going.”
“The treatment stabilized him.”
“According to what data?”
Daniel hesitated.
Sarah placed two patient files on the screen.
Noah: Subject N-04.
Lucas: Subject L-04.
Their names had been disguised as laboratory samples.
Not patients.
Samples.
Jonathan stared at Daniel.
“You buried children inside preclinical records.”
Daniel whispered:
“Keller did.”
“Under your credentials.”
“Yes.”
“Why didn't you report him?”
Daniel looked at me.
“Because he told me if I did, he’d report Vanessa for consenting to an illegal trial and have the boys removed from her custody.”
Vanessa had been manipulated too.
That didn't absolve Daniel.
But it changed the shape of the crime.
Sarah opened the financial audit.
“Keller received more than a million dollars. But we also found $418,000 paid directly to an account controlled by you.”
Daniel’s face went blank.
There it was.
The line between desperate uncle and willing participant.
I turned the screen.
“What was that money for?”
He said nothing.
“Was that for the boys too?”
Still nothing.
Sarah clicked once.
A purchase record appeared.
Luxury watches.
Travel.
A private car lease.
And a deposit on a condominium outside Zurich.
Daniel finally whispered:
“It wasn't supposed to come from research money.”
I stared at him.
“You knew.”
He looked at me.
Not like my husband.
Like a man who had finally reached the wall he had spent three years pretending wasn't there.
Then Jonathan opened another file.
“There’s one thing we haven’t discussed.”
Daniel turned.
Jonathan's expression was grim.
“The gene-therapy vector Daniel used was never developed by Keller.”
I frowned.
“Then who developed it?”
Jonathan looked directly at me.
“Your father did.”
The room went completely silent.
May you like
My father had been dead for twelve years.
And somehow Daniel’s breakthrough had begun with research stolen from my own family.
